Quick Answer
Vitamin K Bone Health Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: MASLD and Bone Markers in Postmenopause: Highlighting the Critical Gap of Vitamin D Status and the Need for Targeted Supplementation Trials.
Key Takeaways
- 01MASLD and Bone Markers in Postmenopause: Highlighting the Critical Gap of Vitamin D Status and the Need for Targeted Supplementation Trials. [Wen X (2026)]
- 02Despite its many benefits, weight loss is also associated with loss of bone and lean mass [,]. [He Jiahuan Helen (2026)]
- 034-8 5-8 9 Look AHEAD (Action for Health in Diabetes) was a multicenter randomized controlled trial aimed at assessing whether long-term weight loss-targeted intensive lifestyle intervention (ILI), involving dietary restriction and increased physical activity, could lower cardiovascular morbidity and mortality in people with overweight/obesity and T2D. [He Jiahuan Helen (2026)]
- 04In addition to its cardiometabolic benefits, the intervention was found to be associated with bone loss []. [He Jiahuan Helen (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin K Bone Health Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- MASLD and Bone Markers in Postmenopause: Highlighting the Critical Gap of Vitamin D Status and the Need for Targeted Supplementation Trials. [Wen X (2026); evidence level 4]
- Despite its many benefits, weight loss is also associated with loss of bone and lean mass [,]. [He Jiahuan Helen (2026); evidence level 4]
- 4-8 5-8 9 Look AHEAD (Action for Health in Diabetes) was a multicenter randomized controlled trial aimed at assessing whether long-term weight loss-targeted intensive lifestyle intervention (ILI), involving dietary restriction and increased physical activity, could lower cardiovascular morbidity and mortality in people with overweight/obesity and T2D. [He Jiahuan Helen (2026); evidence level 4]
- In addition to its cardiometabolic benefits, the intervention was found to be associated with bone loss []. [He Jiahuan Helen (2026); evidence level 4]
- 1 2 3 Weight loss through healthy lifestyle interventions has been linked to a wide range of metabolic benefits in people with type 2 diabetes (T2D) []. [He Jiahuan Helen (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources